Skip to content

Roivant Sciences ROIV Net debt / EBITDA

Net debt / EBITDA at other companies

Amgen logo
AmgenAMGN
3.7×-0.7×
Moderna logo
ModernaMRNA
-2.8×-2.9×
Royalty Pharma logo
Royalty PharmaRPRX
5.2×+1.4×
ALN
Alnylam PharmaceuticalsALNY
-1.8×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×-0.3×
Incyte logo
IncyteINCY
-2×-0.8×

Other financials

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$22.44B+175%
Enterprise value$21.13B+157%
P/S2,716.9×+2,436×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Calculated from Roivant Sciences’s reported figures.

Based on the most recent quarter.

The official record: Roivant Sciences’s 10-Q, filed November 12, 2024, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's net debt / EBITDA?
Roivant Sciences (ROIV) reported net debt / EBITDA of -0× in Q3 2024.
What does net debt / EBITDA mean?
How many years of operating earnings it would take to pay off the company's net debt.
How do you interpret net debt / EBITDA?
Lower is safer; lenders often covenant around 3–4×. A negative value means net cash (more cash than debt), a position of strength. Spikes can reflect a temporary EBITDA dip rather than new borrowing.
How does net debt / EBITDA compare across companies?
A standard leverage yardstick across non-financial sectors; covenant thresholds vary by industry cash-flow stability.